Security key
09073Q105
- Security type / class
- Equity / ADSs
- Total 13F shares
- 311,298
- Total 13F value
- $891,000
- Share change
- +27,680
- SEC-reported price per share
- $2.86
- Number of holders
- 15
- Value change
- -$9,852
- Number of buys
- 8
- Number of sells
- 7
- Shares outstanding
- 592,878
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
15
Top holders
10
BVXV full security history
Ownership snapshot
Full 13F holder table
Scinai Immunotherapeutics Ltd. SEC filings
Scinai Immunotherapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
STATE STREET CORP
Disclosed value leader
STATE STREET CORP
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
STATE STREET CORP leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens STATE STREET CORP's linked filing trail.
Comparable ownership
Top 5
STATE STREET CORP
13%
MORGAN STANLEY
7%
HRT FINANCIAL LP
5.4%
CITADEL ADVISORS LLC
4.9%
GOLDMAN SACHS GROUP INC
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| STATE STREET CORP |
13F
Company
|
13%
|
$296,000
77,911 shares
|
— | 31 Mar 2021 |
| MORGAN STANLEY |
13F
Company
|
7%
|
$157,000
41,521 shares
|
— | 31 Mar 2021 |
| HRT FINANCIAL LP |
13F
Company
|
5.4%
|
$121,000
31,961 shares
|
— | 31 Mar 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
4.9%
|
$111,000
29,300 shares
|
— | 31 Mar 2021 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
4.6%
|
$103,000
26,998 shares
|
— | 31 Mar 2021 |
| Virtu Financial LLC |
13F
Company
|
3.1%
|
$70,000
18,328 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
311,298
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
17
Q2 2021 holders
15
Holder diff
-2
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|